Phosphorothioate Oligonucleotides Inhibit Human Immunodeficiency Virus Type 1 Fusion by Blocking gp41 Core Formation

MLA

Roger G. Ptak, et al. “Phosphorothioate Oligonucleotides Inhibit Human Immunodeficiency Virus Type 1 Fusion by Blocking Gp41 Core Formation.” Antimicrobial Agents and Chemotherapy, vol. 50, no. 4, Mar. 2006, pp. 1393–401. EBSCOhost, https://doi.org/10.1128/aac.50.4.1393-1401.2006.

APA

Roger G. Ptak, Carol Lackman-Smith, Hong Lu, Jean-Marc Juteau, Shuwen Liu, Shibo Jiang, & Andrew Vaillant. (2006). Phosphorothioate Oligonucleotides Inhibit Human Immunodeficiency Virus Type 1 Fusion by Blocking gp41 Core Formation. Antimicrobial Agents and Chemotherapy, 50(4), 1393–1401. https://doi.org/10.1128/aac.50.4.1393-1401.2006

Chicago

Roger G. Ptak, Carol Lackman-Smith, Hong Lu, Jean-Marc Juteau, Shuwen Liu, Shibo Jiang, and Andrew Vaillant. 2006. “Phosphorothioate Oligonucleotides Inhibit Human Immunodeficiency Virus Type 1 Fusion by Blocking Gp41 Core Formation.” Antimicrobial Agents and Chemotherapy 50 (4): 1393–1401. doi:10.1128/aac.50.4.1393-1401.2006.